Dodge & Cox’s AbbVie ABBV Stock Holding History

Dodge & Cox’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Hold	10,393	–	–	﹤0.01%	158
2026 Q1	$2.26M	Hold	10,393	–	–	﹤0.01%	160
2025 Q4	$2.37M	Sell	10,393 -80	-0.8%	-$18.2K	﹤0.01%	154
2025 Q3	$2.42M	Hold	10,473	–	–	﹤0.01%	152
2025 Q2	$1.94M	Hold	10,473	–	–	﹤0.01%	156
2025 Q1	$2.19M	Sell	10,473 -533	-5%	-$104K	﹤0.01%	150
2024 Q4	$1.96M	Hold	11,006	–	–	﹤0.01%	153
2024 Q3	$2.17M	Hold	11,006	–	–	﹤0.01%	147
2024 Q2	$1.89M	Hold	11,006	–	–	﹤0.01%	146
2024 Q1	$2M	Hold	11,006	–	–	﹤0.01%	145
2023 Q4	$1.71M	Sell	11,006 -170	-2%	-$24.8K	﹤0.01%	146
2023 Q3	$1.67M	Sell	11,176 -34	-0.3%	-$4.99K	﹤0.01%	143
2023 Q2	$1.51M	Hold	11,210	–	–	﹤0.01%	145
2023 Q1	$1.79M	Hold	11,210	–	–	﹤0.01%	144
2022 Q4	$1.81M	Hold	11,210	–	–	﹤0.01%	140
2022 Q3	$1.5M	Buy	11,210 +2	+0%	+$287	﹤0.01%	143
2022 Q2	$1.72M	Sell	11,208 -70	-0.6%	-$10.7K	﹤0.01%	141
2022 Q1	$1.83M	Sell	11,278 -124	-1%	-$18K	﹤0.01%	144
2021 Q4	$1.54M	Sell	11,402 -4,000	-26%	-$473K	﹤0.01%	144
2021 Q3	$1.66M	Hold	15,402	–	–	﹤0.01%	138
2021 Q2	$1.74M	Hold	15,402	–	–	﹤0.01%	138
2021 Q1	$1.67M	Hold	15,402	–	–	﹤0.01%	138
2020 Q4	$1.65M	Hold	15,402	–	–	﹤0.01%	139
2020 Q3	$1.35M	Sell	15,402 -360	-2%	-$33.9K	﹤0.01%	144
2020 Q2	$1.55M	Sell	15,762 -640	-4%	-$56.3K	﹤0.01%	136
2020 Q1	$1.25M	Sell	16,402 -600	-4%	-$51.1K	﹤0.01%	133
2019 Q4	$1.5M	Sell	17,002 -14,000	-45%	-$1.16M	﹤0.01%	138
2019 Q3	$2.35M	Sell	31,002 -107	-0.3%	-$7.34K	﹤0.01%	126
2019 Q2	$2.26M	Sell	31,109 -183	-0.6%	-$14.4K	﹤0.01%	128
2019 Q1	$2.52M	Hold	31,292	–	–	﹤0.01%	125
2018 Q4	$2.88M	Hold	31,292	–	–	﹤0.01%	122
2018 Q3	$2.96M	Buy	31,292 +1,700	+6%	+$161K	﹤0.01%	122
2018 Q2	$2.74M	Hold	29,592	–	–	﹤0.01%	118
2018 Q1	$2.8M	Sell	29,592 -104	-0.4%	-$11.4K	﹤0.01%	118
2017 Q4	$2.87M	Sell	29,696 -2,200	-7%	-$207K	﹤0.01%	120
2017 Q3	$2.83M	Sell	31,896 -1,336	-4%	-$102K	﹤0.01%	120
2017 Q2	$2.41M	Hold	33,232	–	–	﹤0.01%	120
2017 Q1	$2.17M	Hold	33,232	–	–	﹤0.01%	123
2016 Q4	$2.08M	Hold	33,232	–	–	﹤0.01%	123
2016 Q3	$2.1M	Hold	33,232	–	–	﹤0.01%	121
2016 Q2	$2.06M	Hold	33,232	–	–	﹤0.01%	118
2016 Q1	$1.9M	Sell	33,232 -23	-0.1%	-$1.28K	﹤0.01%	121
2015 Q4	$1.97M	Hold	33,255	–	–	﹤0.01%	124
2015 Q3	$1.81M	Sell	33,255 -1,000	-3%	-$65.1K	﹤0.01%	117
2015 Q2	$2.3M	Sell	34,255 -800	-2%	-$52.2K	﹤0.01%	111
2015 Q1	$2.05M	Sell	35,055 -3,000	-8%	-$181K	﹤0.01%	117
2014 Q4	$2.49M	Sell	38,055 -794	-2%	-$50.1K	﹤0.01%	116
2014 Q3	$2.24M	Buy	38,849 +2,200	+6%	+$122K	﹤0.01%	115
2014 Q2	$2.07M	Sell	36,649 -52	-0.1%	-$2.73K	﹤0.01%	115
2014 Q1	$1.89M	Buy	36,701 +52	+0.1%	+$2.63K	﹤0.01%	115
2013 Q4	$1.94M	Sell	36,649 -516	-1%	-$25.4K	﹤0.01%	112
2013 Q3	$1.66M	Sell	37,165 -100	-0.3%	-$4.43K	﹤0.01%	119
2013 Q2	$1.54M	Buy	+37,265	New	+$1.63M	﹤0.01%	120

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox's ABBV Position: Q2 2026 in Review

Dodge & Cox held its AbbVie (ABBV) position steady in Q2 2026 at 10,393 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #158.

Dodge & Cox first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.96M in Q3 2018. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Dodge & Cox held 10,393 shares of AbbVie worth $2.62M as of Q2 2026.
Dodge & Cox left its AbbVie share count unchanged in Q2 2026.
AbbVie made up ﹤0.01% of Dodge & Cox's portfolio in Q2 2026, its #158 holding.
Dodge & Cox first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Dodge & Cox's AbbVie position peaked at $2.96M in Q3 2018.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.